Last reviewed · How we verify
Mometasone Furoate Cream
At a glance
| Generic name | Mometasone Furoate Cream |
|---|---|
| Also known as | Eloson, Elocon, topical steroid cream, Nasonex |
| Sponsor | Yao Liao |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Safety and Efficacy of Intralesional 0.5% Triamcinolone Acetonide in 0.2% Fluconazole Solution vs 0.1% Topical Mometasone Furoate With 2% Miconazole Nitrate Cream in the Treatment of Chronic Paronychia: An Intraindividual Randomized Controlled Trial. (PHASE3)
- 0.005% Latanoprost Gel for Nonsegmental Vitiligo (PHASE2)
- Prebiotic Effects of Mulberry Fruit in Children and Adolescents With Atopic Dermatitis (NA)
- Comparison of Effectiveness and Safety of Triple Combination Cream of Fucinolone Acetonide 0.01%, Hydroquinone 4%, Tretinoin 0.05% with Mometasone Furoate 0.1%, Hydroquinone 4%, Tretinoin 0.05% in the Treatment of Melasma (NA)
- Dermatitis During Adjuvant Irradiation for BREAst Cancer: (NA)
- Elocon vs Fluticasone in Localized Psoriasis (P03197) (PHASE4)
- Evaluation of Efficacy and Safety of Enhanced External Counter-pulsation on Patients With Atopic Dermatitis and Inflammatory Skin Disease Requiring Wet Wrap Therapy (NA)
- Improvement of Psoriasis Patients' Adherence to Topical Drugs (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Mometasone Furoate Cream CI brief — competitive landscape report
- Mometasone Furoate Cream updates RSS · CI watch RSS
- Yao Liao portfolio CI